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It was found in the experiments  to be described  that many steroids  in the 
androstane series profoundly retard the growth of a transplanted benign mam- 
mary tumor in adult intact female rats. This paper is concerned with the rela- 
tionship of the molecular structure of these steroids  to their inhibitory effects 
on the tumor and with mechanisms  involved in the depression  of neoplastic 
growth by these agents. A quantitative relationship was found to exist between 
the dosage of the steroid administered and the extent of the restraint of the 
tumor which ensued. In the variations of its growth rate in response to hormonal 
modifications  the benign tumor of the rat resembles some human mammary 
carcinomas, and in this regard it is a serviceable laboratory model that is unique 
at the present time. The growth of the transplanted tumor is accelerated  or 
retarded by hormones which already have been found through clinical practice 
to have like effects on carcinoma of the breast of the human being. The avail- 
ability of quantitative methods of study of a hormone-responsive experimental 
tumors expands the scope of investigation of mammary neoplasms. 
The  mammary fibroadenoma  employed  in  the experiments  has  two  out- 
standing characteristics.  It is a neoplasm.  Secondly, the tumor possesses some 
of the responsiveness to hormones which is characteristic of normal mammary 
epithelium of the rat in so far as its growth rate is profoundly altered by the 
administration or withdrawal of appropriate hormones.  With respect  to the 
promotion of growth by steroid and protein hormones, it was shown earlier (1) 
that there are many similarities  in the reactivity of both the transplanted 
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fibroadenoma and the normal mammary tree of its host to these agents but 
that striking differences of response also exist. It is evident that the neoplastic 
transformation of mammary epithelium has resulted in a loss of certain growth 
characteristics and in a gain of others; these matters will be considered further 
in this paper. 
The benign mammary fibroadenoma studied  in the present work grows to 
a  considerable  size  within  50  days in  normal  adult  female rats  whereas  its 
growth is slight after the ovaries have been removed; the retarding effect of 
ovariectomy upon the growth of a similar tumor has been described earlier (2). 
The growth of the tumor is enhanced profoundly in ovariectomized rats by the 
administration of phenolic estrogens in critical quantities, or progesterone (1). 
In  hypophysectomized rats  (1)  the  tumor  grows  indolently  but  after  some 
weeks  active  growth  commences  despite  the  absence  of  growth-promoting 
hormones as determined by absence of growth in the atrophic tissues of the 
host--a sensitive biological test. 
It has been learned in clinical practice (3) that testosterone can cause regression of 
the neoplasm in certain women with advanced mammary cancer and several related 
steroids,  17a-methyltestosterone and dihydrotestosterone, have been found to have 
a similar beneficial activity; the effectiveness of these compounds has been reviewed 
recently (4). The mechanisms involved in the restraint of human mammary cancer 
by androstane compounds are unclear. Segaloff d  al. (5) observed that testosterone 
uniformly produced a  decrease in  the  urinary excretion  of gonad-stimulating hor- 
mones in the human; the consequent decrease of ovarian function would appear to be 
significant  in some cases in the regression  of the neoplasm. The decrease  of gonado- 
trophin production does not account satisfactorily for the well established regression 
of mammary cancer induced by testosterone in many ovariectomized or postmeno- 
pansal women. 
Heiman and Krehbiel (2) found that mammary fibroadenoma grew slowly in the 
intact male rat and that the rate of tumor growth increased slightly after orchiectomy. 
Testosterone is the only compound in the androstane series which  has been studied 
for its growth inhibitory effects on this tumor. Heiman (6) found that the administra- 
tion of this steroid to male and female rats bearing grafts of mammary fibroadenoma 
reduced the number of "takes" and retarded the subsequent growth of the tumor. 
In the experiments of Miliar and Noble (7) testosterone caused slight or no inhibition 
of growth of the  transplanted rat mammary fibroadenoma which  they employed. 
The inhibitory effects of testosterone and certain related compounds to be reported 
in this paper are of much greater magnitude than has been reported in experiments 
of other workers. 
In  the  present  experiments,  the  effects of hormonal modifications  on  the 
growth of transplanted mammary fibroadenoma were correlated in each case 
with  growth  in  the  mammary glands  of its host.  The  determination  of the 
alkaline phosphatase content of one of the breasts is a  simple and valid tech- 
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advantageous  since  the  activity  of  the  enzyme  can  be  correlated  by  histo- 
chemical  methods  with  its  site  in  the  contralateral  mammary  gland.  Folley 
and  Greenbaum  (8)  have found  that the  alkaline  phosphatase  content of  the 
mammary  gland  increases  rapidly  and  greatly  during  pregnancy  in  the  rat. 
It has been shown  (1)  that  the removal of the ovaries from adult  rats results 
in a  considerable decrease in the content of this enzyme in the mammary  gland 
and,  conversely,  that  the  administration  of  increasing  amounts  of  phenolic 
estrogens  to  these  ovariectomized  rats  causes  a  progressive  increase  in  the 
alkaline phosphatase  content of the breast until a  high plateau of the quantity 
of this enzyme is reached. 
Methods 
In brief, many fragments  of similar size of benign mammary fibroadenoma were trans- 
planted in groups consisting of many rats of the same age reared under similar laboratory con- 
ditions  and  the  tumors  were harvested  50  days later;  the experimental  variable was  the 
altered steroid status of the host. The mammary fibroadenoma used in the experiments had 
arisen in our laboratory as previously described  (1)  and had been maintained by successive 
transplantations over a period of 2 years. 
Albino rats of the Sprague-Dawley strain were obtained from the dealer at age 42 days and 
kept thereafter under controlled climatic conditions. The rats were fed a  commercial ration 
except that hypophysectomized rats were maintained on a steroid-free high protein diet (9). 
The experiments were carried out on 16 series of female rats. Each series contained 102 to 
106 rats which were divided in 11 groups of 9 to 16 animals. In order to establish control param- 
eters of  tumor growth  two of the groups were not  injected with  steroids;  these consisted, 
respectively, of normal and castrate females. In addition, in many series the tumor was trans- 
planted to intact and castrate males and hypophysectomized female rats. Characteristic vari- 
ations in the growth rate of the tumor in untreated intact male and female rats as contrasted 
with its growth in animals from which the gonads or the hypophysis had been removed, always 
at age 42 to 44 days, were regarded as functional tests of the growth capacity and hormonal 
dependence of the tumor. The surgical operations and the transplantation of tumors were per- 
formed under ether anesthesia. Nine groups each consisting of 9 intact female rats were in- 
jected with steroids in every series. 
The tumor was transplanted to the groups of recipients when they were 51 days old. The 
donor in each case was an intact adult female bearing a large tumor. The tumor was excised, 
sliced, and oval fragments were cut from the slices with a surgical punch. The implants meas- 
ured about 8 x 5 x 5 ram. and weighed about 50 to 70 rag.  Every tenth fragment was weighed 
and the standard deviation of these weights was calculated. Either four, or preferably eight, 
pieces of tumor were implanted subcutaneously in widely separated places through small inci- 
sions  in the interscapular region and in the epigastrinm. 
The steroids  ~  were dissolved in ethyl alcohol which was diluted with sesame oil to make the 
final alcoholic concentration 10 per cent. The solution (0.2 ml.) was injected subcutaneously 
6 days each week for 7 weeks.  Throughout  this paper dosage refers to the amount administered 
each day. 
1 We acknowledge with gratitude generous gifts of compounds used  in these experiments 
from Dr. H. J. Ringold, Syntex, S. A., Mexico City, Dr. Victor Drill, G. D. Searle & Co., 
Chicago; Dr. Edward Henderson,  Sobering Corporation, Bloomfield, New Jersey; Dr. Karl 
Junkmann, Schering, A. G., Berlin, Germany; and Dr. E. V. Jensen, TheBen May Laboratory 
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At necropsy,  always .50 to 52 days after transplantation, the tumors, preputial glands, 
prostates, ovaries, and uteri were weighed on a precision balance. Histologic preparations of 
tumors from each group were always studied. The site of alkaline phosphatase was determined 
in histological preparations of  the  tumor,  the  mammary glands and  the  vagina  by  the 
method of Gomori (10). 
The content of alkaline phosphatase was determined in a mammary gland in the inguinal 
region: adipose tissue containing mammary tubules was excised from a  triangle hounded by 
the inguinal ligament, the deep epigastric vein and the midline. This tissue was spread on filter 
paper and, for convenience, immersed in a large volume of ice-cold acetone for 2 to 9 hours. 
After evaporation of acetone in an evacuated desiccator for 15 hours each gland was homoge- 
nized in 5 ml. of water, centrifuged and the supernatant solution was filtered. The alkaline 
TABLE  I 
Growth of Transplants  of Two Mammary Fibroadenomas of  Varying  Degrees of Hormonal 
Dependence in Intact, Castrate, and Hypophyseaomined Rats 
There were 9  rats in each category; necropsy was performed, at age  101 days, 50 days 
after transplantation of the different tumors. The rats were untreated. 
I 
I  Mean tumor weight  Category 
(a)  Tumor with high hormonal dependence 
Intact females ................................................. 
Castrate females ............................................... 
Castrate males ................................................ 
Intact males .................................................. 
Hypophysectomized females ..................................... 
(b)  Tumor with less hormonal dependence 
Intact females .................................................. 
Castrate females ................................................ 
Castrate males ................................................. 
Intact males ................................................... 
Hypophysectomized females ...................................... 
1454 
163 
102 
73 
46 
2702 
1731 
476 
367 
100 
phosphatase content was determined by the method of King and Armstrong (11)  and the re- 
sults are expressed in the units of  these workers.  In preliminary experiments it was found 
that immersion of the mammary glands in chilled acetone for the brief periods used in  this 
study did not result in a  loss of content of alkaline phosphatase. 
RESULTS 
Histologic study of the tumor transplants did not reveal a  change to car- 
cinoma or sarcoma in any case in the present experiments and metastases were 
never observed at necropsy. 
The transplanted  mammary fibroadenoma was  considered to possess high 
hormonal dependence when,  in  the  absence of treatment  with  steroids,  the 
transplants grew vigorously in intact females and much more slowly in ovariec- 
tomized and hypophysectomized sisters and in males (Table I  a). At the end of CHARLES  HUGGINS  AND  KLAUS  M.AINZER  489 
the experimental  period the mean weight of tumors of this kind was 68 to 190 
rag. in females deprived of ovaries, whereas the values in intact females weighed 
between 443  and 2217 rag. Quantitative values of this sort were obtained in 
nearly all of the experiments and from these considerations  it was apparent that 
the growth rate of the tumor and its state of hormonal dependence  had not 
changed during the experimental period. 
But in 3 experiments to be designated the tumor was less hormone-dependent 
than the foregoing as the functional tests brought out (Table I b). The differ- 
ences were quantitative. These tumors grew  to a  considerable  size in ovari- 
ectomized  rats and in males  during the  experimental  period  although their 
size was smaller  than companion transplants growing in intact females. 
In each of 5 experiments the tumors grew to larger size in castrate males than 
in the intact males  (Table I). The differences, although not large,  were con- 
sistently present. 
Androstane Inhibitors  of Tumor Growtk 
In Table II, data from 3 series of experiments are presented. The values show 
that many compounds  in the androstane series retarded the growth of the 
fibroadenoma  in adult female rats although with varying degrees of potency. 
The monofunctional steroid androstan-3-one  did not retard growth but an- 
drostan-17B-ol was a moderately effective inhibitor. The effects of androstane 
derivatives on tumor growth in intact rats were always related to the growth in 
untreated rats deprived of the ovaries  in the same series. Steroids  were con- 
sidered to be powerful growth inhibitors of the mammary fibroadenoma  when 
the size of the tumor in treated intact rats  was equal  to or  less than the  size 
in ovariectomized  rats.  Dihydrotestosterone and 2a-methyl-androstanl7B-ol- 
3-one fell in this class. 
4-Androstene-3,17-dione,  1 nag., was considered  to be a  weak inhibitor of 
tumor growth because the restraint of growth (Table II), while confirmed in 
repeated experiments, was less than the inhibition resulting from ovariectomy. 
Furthermore, the growth-retarding effects of this steroid and of other inhibi- 
tors were intensified by an increase of dosage (Text-Fig.  1) of the compounds. 
The inhibitory steroids  were observed  to produce  restraint of growth in a 
direct proportional relationship (Text-Figs.  1 and 2) to the amount of the com- 
pound administered until maximal retardation of tumor growth was achieved. 
Many compounds in the androstane series exceeded 4-androstene-3,17-dione 
in their potency as inhibitors of mammary fibroadenoma  (Table  II, Fig.  1). 
These included in ascending  order of effectiveness  (Table II)  androsterone, 
testosterone,  and dihydrotestosterone. No modification  of the rate of tumor 
growth was observed from the administration of etiocholan-17fl-ol-3-one, 1 to 
5 rag. or ep/testosterone,  1-2 rag. 
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been removed; in each study 1 group received dihydrotestosterone, 1 mg., while 
a  similar lot was not  treated with steroids. In each of these experiments the 
tumors grew at a  slower rate in the ovariectomized rats receiving dihydrotes- 
tosterone than in their uninjected ovariectomized mates (Table III). 
TABLE IT 
The Effect of Removal of the Ooaries Compared with Administration of Steroids to Intact Adult 
Female Rats  in Retardation of Growth of  Mammary  Fibroadenoma 
There were 9 rats in each group and in each experiment there were groups of intact and 
ovariectomized females which were  not injected. The steroids were  injected, 1 rag.  daily, 
for 50 days; A is the gain in body weight of these rats during this period. Alkaline  phosphatase 
indicates the content of this enzyme in the inguinal mammary gland. The mean weights of 
the tumors, ovaries, preputial glands, and the ventral prostate are given. 
Compound 
~.ndrostan-17-one 
[-Androstene-3,17- 
dione 
kndrostan-17~-ol:~ 
~ndrostan-3a-ol-17- 
one (androsterone) 
[-Androsten-17~-ol-3- 
one (testosterone) 
kndrostan-17/~-ol-3- 
one(dihydrotestos- 
terone) 
.~a-Methylandrostan- 
175-ol-3-one 
gra. 
88 
130 
132 
123 
130 
127 
153 
Tumor weight 
In° 
Unlnjected  jected 
Intact  Ovarl-  Intact  ectomy 
rag.  rag.  mg. 
917  190  1731 
1920!  120  873 
917  I  190  473 
677  88  258 
i 
1117  68  114 
l 
917  190  76 
! 
1920  120  48 
Ova~es 
rag. 
104 
35 
57 
92 
33 
35 
37 
Preputial 
islands 
rag. 
129 
241 
147 
254 
262 
450 
266 
Ventral 
prostate 
rag. 
0 
116 
27 
94 
103 
271 
134 
Alkaline 
phosphatase 
u~its* 
1.30  4- 0.4 
1.59  -4- 0.3 
3.35  4- O.5 
1.23  ±  0.3 
2.10  4-  0.3 
3.10  ±  0.4 
3.90  ±  0.3 
* King and Armstrong units with standard deviation. 
:~ Daily dosage, 2 mg. 
Supplementary  Oxygen  Functions.--The  addition  of  oxygen  substituents, 
ketone or hydroxyl, at positions 6,  15a, or 16a, abolished the tumor inhibitory 
effects of testosterone and dihydrotestosterone. 
Supplementary Methyl Groups  .--With  respect to the inhibition of growth of the 
mammary tumor, the addition of 1 or more methyl groups to potent inhibitory 
compounds in the androstane series considerably modified the effectiveness of 
the parent compounds, enhancing it in some steroids and destroying it in others. 
The effect on growth of the addition of methyl groups at positions 2, 3, 4,  16, 
or 17 to compounds in the androstane series was examined. CHARIES  tt-GGGINS AND  KLAUS  MAINZER  491 
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T~cr-FzO. I. The weight of transplanted  mammary fibroadenoma in rats treated with ,13 
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TExT-FIe. 2. Depression of the weight of mammary fibroadenoma and increase of alkaline 
phosphatase  in  the inguinal  mammary  gland  induced  by increasing doses of testosterone. 
Ordinates on the left indicate the weight of the tumor and on the right the content of alkaline 
phosphatase in the mammary gland expressed  in King and Armstrong units; these data are 
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2a-Methyldihydrotestosterone  and  2a, 17a-dimethyldihydrotestosterone 
were found to be powerful inhibitors (Table III) of the growth of the mammary 
tumor. The presence of two methyl groups at C~ destroyed the tumor-restrain- 
ing  effects of steroids;  2,2'-dimethyl-,  and  2,2', 17a-trimethyldihydrotestos- 
terone exerted no significant inhibitory activity on the neoplasm (Table Ill). 
A  methyl group situated at  C8 eliminated the tumor-inhibitory activity of 
steroids;  3a-methylandrostane-3/3,17¢~-diol,  1 rag.,  and 3O-methylandrostane- 
3a, 17O-diol,  1 rag., were ineffective in this regard. 4,4'Dimethyldihydrotestos- 
terone,  1 rag.,  16a-methylandrosterone,  1 mg., and  16-methylenandrosterone, 
TABLE HI 
Effect of Additional Methyl Substituents in Androstane Compounds on the Retardation of Growth 
in Adult Intact Rats 
The steroids, 0.1 nag. daily, were injected for 50 days with 9 rats in each group. The mean 
weights of the tumor, the ovaries, and the preputial glands are given. Alkaline phosphatase 
indicates the content of this enzyme in the in uinal mammary gland. 
Compound and daily dose 
2,2'-17a-Trimethyldihydrotestosterone ....... 
Intact: no injections. 
2,2'-Dimethyldihydrotestosterone. 
Dihydrotestosterone. 
la, 17a-Dimethyldihydrotestosterone. 
~a-Methyldihydrotestosterone  .... 
)variectomized: no injections. 
3variectomized: Dihydrotestosterone;~. 
"~mlo: 
welghl 
mg. 
8867 
2217 
896 
486 
271 
263 
186 
101 
Ovaries 
mg. 
82 
87 
85 
68 
7O 
68 
Preputial 
glands 
mg. 
103 
121 
124 
168 
148 
144 
105 
276 
Alkaline 
phosphstase 
unigs* 
1.484-  0.1 
1.43 4-  0.4 
1.48  -4- 0.3 
1.83  ~  0.4 
2.84  4-  0.4 
2.53  4-  0.9 
1.15 -4- 0.2 
3.55  ~  0.3 
* King and Armstrong units with standard deviation. 
The daily dosage of dihydrotestosterone was 1 rag. 
1 mg., possessed no inhibitory effects.  17a-Methyltestosterone,  1 rag.,  was a 
potent inhibitor of growth of the tumor. 
3-Hydro~st~o~s.--The  steric position of an hydroxyl group at C8 in com- 
pounds in the androstane series exerted a  remarkable influence on the growth 
of the neoplasm. Steroids with an hydroxyl group in the 3/3 configuration were 
weak inhibitors or actually accelerated the growth of mammary fibroadenoma 
whereas related compounds with a 3~-hydroxyl group retarded  growth of the 
tumor to great extent. An  acceleration  of growth  of the tumor resulted from 
the administration of 5-androstene-3~, 17~-diol, dehydroel0~androsterone or el~ 
androsterone  (Table  IV);  4-androstene-3~,17~-diol  was  a  weak  inhibitor  of 
tumor growth. The injection of androsterone considerably retarded the growth 
of the tumor and 4-androstene-3a, 1  7~-diol was a  powerful inhibitor. CHARLES  HUGGINS  AND  K.LAUS MAINZER  493 
Dihydrotestosterone Restrained  the Stimulation  of Growth of Benign Mammary 
Fibroadenoma in the Presence of Estradiol-17fl or Progesterone 
Earlier  (1) it had been shown that progesterone, 4 rag.,  or estradiol-170,  1 
#g.,  enhances very considerably the growth of transplanted  fibroadenoma in 
ovariectomized rats. In the present experiments the same effects were observed 
when these steroids were administered to intact rats (Table V). The profound 
stimulation of tumor growth induced by these steroids, administered separately 
(Table V) or together (Fig. 1) was completely abolished by the additional ad- 
ministration  of dihydrotestosterone,  1 rag. 
TABLE IV 
Differential Effects of 3 alpha- and 3 beto,-Hydroxysteroids on Growth of Mammary Fibroadenoma 
in Adult Intaxt Female Rats 
The steroids were injected for 50 days with 9 rats in each group. The mean weight of the 
tumor, ovaries, and preputial glands is given. Alkaline phosphatase indicates the content of 
this enzyme in the inguinal mammary gland. 
Compound and daily dose 
5-Androstene-3fl,  17fl-diol, 2 mg 
~ndrostan-3t~-ol-17-one,  3  rag.  (ep/androster- 
one) 
~-Androsten-3fl-ol-17-one,  3  mg.  (Dehydroepi- 
androsterone) 
Intact: no injections. 
t-Androstene-3fl, 17fl-diol, 0.5 nag. 
kndrostan-3a-ol-17-one,  1 nag. (androsteroue).. 
l-Androstene-3~,lT~-diol, 0.5 nag.. 
3variectomized: no injections. 
Tumor 
weight 
m&. 
1600 
1177 
915 
520 
366 
133 
92 
86 
Ovaries 
mg. 
35 
87 
54 
92 
75 
80 
31 
Preputial 
glands 
mg. 
307 
321 
293 
125 
207 
222 
309 
109 
Alkaline 
phosphatase 
uslts* 
2.33  4-  0. 
1.35  4-  0. 
2.24  -4-  0., 
1.46  -4-  0. 
1.63  -t-  0., 
1.11  4-  0. 
3.09-4-0. 
0.97  +  0. 
* King and Armstrong units with standard deviation. 
Dihydrotestosterone  induced  marked  growth  of  the  prostate,  preputial 
glands,  and the mammary glands with a pronounced increase of alkaline phos- 
phatase in the latter. The simultaneous administration of estradiol-17fl,  I  #g., 
and dihydrotestosterone did not modify significantly  these growth processes or 
the content of alkaline phosphatase in the mammary gland (Table V). 
Dikydrotestosterone Failed to Retard the Growth of Mammary Fibroadenoma 
of Low Hormonal Dependence 
In  this  experiment,  repeated  on  3  occasions,  the  transplanted  mammary 
fibroadenoma was more refractory to experimental hormonal changes than any 
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inferred from (a) equal growth in ovariectomized and intact female hosts and 
(b)  uncommonly brisk growth  in hypophysectomized rats  (Table  VI).  From 
histologic examination  no differences were evident between the refractory tumor 
and the ordinary sort. Dihydrotestosterone, 1 rag., failed to retard the growth 
TABLE V 
Inhibitory Effect of Dihydrotestosterone on the Growth of Mammary  Fibroadenoma When 
Administered witk Estradiol-17fl or Progesterone 
The steroids were administered for 50 days with 9 intact female rats in each group. The 
mean weights of the tumor and the preputial glands are given. Alkaline phosphatase indi- 
cates the content of this enzyme in the inguinal mammary gland. 
Steroids, with daily dosage 
brogesterone, 4 nag. 
]stradiol-17B, lt~g 
ntact females; no injections. 
}variectomized;  no injections. 
)Lhydrotestosterone, 1 mg.. 
)ihydrotestosterone, 1 mg. and estradiol-17fl, 1 ~g... 
)ihydrotestosterone, 1 rag. and progesterone, 4 mg.. 
* King and Armstrong units with standard deviation. 
TuInor 
weight 
mg. 
3647 
1986 
443 
91 
60 
58 
55 
Preputial 
glands 
rag. 
123 
116 
106 
119 
264 
288 
399 
Alkaline 
phosplmtase 
~nita* 
3.23  +  1.09 
1.96 -4- 0.47 
1.56  +  0.58 
1.27  -4- 0.11 
3.54 4- 0.25 
3.75  -v 0.23 
3.17  4- 0.27 
TABLE  VI 
Failure of Dihydrotestosterone to Block the Growth of Mammary Fibroadenoma in Hypophysec- 
tomized Rats 
Six fragments of tumor were transplanted in each rat, with 9 female rats in each class. 
One group  of hypophysectomized rats  was  injected  with  dihydrotestosterone;  the  other 
groups were untreated. 
Class  Surviving transplants  Mean tumor weight 
Intact  ....................................... 
Ovariectomized .............................. 
Hypophysectomized: uninjected ............... 
Hypophysectomized  +  dihydrotestosterone,  1 
mg  ........................................ 
pot cent 
59 
75 
88 
93 
mg. 
1127 
1193 
370 
691 
of this tumor in hypophysectomized rats  (Table VI). This steroid caused ex- 
tensive growth of the mammary glands in all of the hypophysectomized hosts 
of the tumor. 
Effects of Tumor-Inhibitory Steroids on Growth of Normal Tissues 
All of the steroids in the androstane series which inhibited the growth of the 
mammary fibroadenoma possessed common properties of increasing the size of CHARLES  HUGGINS  AND  KLAUS  MAINZER  495 
certain normal organs whilst decreasing that of others. Prominent amongst the 
augmented growth effects is a gain of body weight which exceeded that occur- 
ring in uninjected mates. Moreover, the steroids induced selective enlargement 
of preputial glands,  the  vestigial  prostatic  glands  (when  present),  and  the 
breasts.  The ovaries were often but not invariably reduced in size. 
During the experiment,  130 intact rats implanted with tumor but uninjected 
with steroids gained 76 to 114 gm.; the mean increase in their body weight was 
95.1 4-  9 gm. In all groups of rats injected with potent tumor-inhibitory ster- 
oids in the androstane series (Table II) the increases of body weight exceeded 
these values. The greatest weight gain occurred in rats injected with 2c~-methyldi- 
hydrotestosterone in which the mean increase in body weight was 153 gin. 
At the end of the experiments the weight of the preputial glands of 50 unin- 
jected tumor-bearing intact female rats was 109 ~  22 rag. In these untreated 
animals the vestigial prostate was visible  in the gross in 18  rats; the mean 
weight was 5.1 q- 0.6 rag. In rats injected with each of the powerful tumor- 
inhibitory steroids the mean values of the weight of the preputial and prostatic 
glands were considerably  increased  (Table  II) above the control values. 
Growth of the mammary glands was induced by all of the compounds in the 
androstane series which restrained the growth of the mammary tumor. These 
compounds  produced  enlargement and redness  of the nipples.  The enlarged 
mammary glands were thick, orange in color, and of firmer consistency than the 
adipose tissue which encased them. On microscopic examination it was found 
that the large  size consisted  of an increase  both in number and  in  size of 
the mammary tubules. There was also an augmentation in the secretion in the 
tubules, manifested  by an  increase  in neutral fat and alkaline  phosphatase 
as demonstrated by histochemical means. When growth of the mammary gland 
was induced by steroids the content of alkaline phosphatase in the mammary 
gland was considerably  elevated above  that of the breasts of uninjected rats 
(Tables  II to V). 
The growth of the mammary glands was not confined to rats in which the 
members of the androstane series were inhibitors of the tumor. Related steroids 
which  promoted the growth of the tumor induced growth of  the mammary 
gland equally as pronounced  as that effected by the  inhibitors;  5-androstene- 
3/~, 17/~-diol and dehydroepiandrosterone enhanced the growth of the  tumor, 
induced the growth of large red nipples, and caused marked enlargement of the 
mammary glands with the formation of lobules of alveoli, lactation, and an in- 
crease of alkaline phosphatase. 
Most of the tumor-inhibitory steroids induced a profound decrease in the size 
of the ovaries (Table II) and abolished the formation of keratin in the vagina. 
But the administration of androsterone,  1 to 3 mg. daily, whilst inducing pro- 
gressive retardation of the growth of the tumor, did not result in a decrease in 
ovarian weight (Table II) and in many of these rats keratinization of the vagi- 
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DISCUSSION 
For steroids in the androstane series the molecular structure required for the 
inhibition  of the hormonal dependent mammary fibroadenomas was identical 
with the requirements for the promotion of growth by these compounds of cer- 
tain hormonal targets, notably the mammary glands. There was never restraint 
of tumor growth by any of the compounds without accompanying growth of 
some normal organs. Earlier, Selye et al. (12) discovered that testosterone causes 
proliferation  of the mammary gland of the rat. A bizarre finding in the present 
experiments was the profound inhibition of growth of mammary tumor trans- 
plants by steroids which were producing vigorous growth of the breasts of the 
host. The prostate and the giant sebaceous preputial glands were also stimulated 
to grow by the tumor inhibitors.  Furthermore, the various tumor inhibitors in 
the androstane series differed only in potency; qualitative differences were not 
observed between them vis-a-vis their effects on either tumor or host. 
The structural factors in the androstane molecule which are of high signifi- 
cance in the retardation of growth of benign mammary fibroadenoma (and the 
promotion of growth of the mammary glands as well) are the number, the posi- 
tion, and the state of oxidation  both of functional groups and alkyl groups3 
These requirements  are reminiscent  of the steroid structure which is effective 
in promoting selective growth of the vagina, uterus (13), and prostate (14) of 
the female hypophysectomized  rat. 
The functional groups which endow these molecules with a tumor-inhibitory 
capacity are hydroxyls and ketones.  These are effective when located at posi- 
tions 3 and 17. The optimal number of these groups is 2. Additional oxygen 
functions, ketone or hydroxyl at positions 6, 15a, or 16a, destroyed the tumor- 
inhibitory effect  of testosterone and dihydrotestosterone. Ketone groups  at 
positions C3 and C1~ are less effective than hydroxyls, in proper orientation, at 
these sites.  The monofunctional steroid  androstan-17/3-ol was an inhibitor of 
tumor growth,  although less effective than dihydrotestosterone; androstan-3- 
one did not influence tumor growth. 
For retardation of tumor growth a special steric orientation of the hydroxyl 
groups  which  are present is preferential or obligatory.  An obligatory steric 
orientation for an hydroxyl group at C17 is beta; whereas testosterone  was a po- 
tent inhibitor,  epitestosterone did not influence the growth of the tumor. With 
reference to position 3, the a-orientation of a hydroxyl group is highly prefer- 
ential for tumor inhibition.  Both ketone groups  and, much more effectively, 
a-oriented hydroxyl groups  contributed to  the  inhibition of  tumor  growth 
whereas most of the steroids  with a  3 r-hydroxyl accelerated  growth of the 
2 In  unpublished experiments on  the  effect of 4-estrene compounds on growth of mam- 
mary fibroadenoma, we have found that 17o~-ethinyl-19-nor-testosterone, 0.5 mg., accelerated 
the  growth of the tumor whereas 17a-ethyl-19-nor-testosterone was a  powerful inhibitor  of 
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tumor. In this wise androsterone restrained  growth of the tumor whilst epi- 
androsterone accelerated  its growth. The site of unsaturation in the molecule 
exerted  an important influence on its effect on tumor growth.  The A4 steroid, 
4-androstene-3~, 17~-diol retarded the growth of the tumor to a slight extent 
whilst its A6 analogue,  5-androstene-3/~, 17/~-diol enhanced  its growth. 
The presence of one or more methyl groups at special sites of the androstane 
molecule exerted an effect on the restraint of tumor growth. Among the com- 
pounds tested, the most powerful steroid for the restraint of mammary fibro- 
adenoma  was  2a-methyldihydrotestosterone. The  introduction  of  a  17a- 
methyl group in this compound or in testosterone did not weaken the tumor- 
inhibitory activity of the parent compound. The presence of two methyl groups 
at position 2 (or at position 4) destroyed the tumor-inhibitory activity of dihy- 
drotestosterone.  Steroids with a 3a- or 3fl-methyl group likewise were inactive 
on growth processes. 
Evidence was derived from the experiments that 2 biological mechanisms are 
operative in the restraint of mammary fibroadenoma  by compounds  in the 
androstane series in intact female rats. These are (a) the depression of hormone 
production by the ovary and (b) the blockade of activity of growth-promoting 
steroids at the level of the tumor cell. 
The hormonal status of the normal adult female rat is very favorable for the 
growth of the tumor and the ovary contributes much to this conducive state 
since ovariectomy considerably  retards the growth of the transplants. Testos- 
terone causes atrophy of the ovary as McEuen et al.  (15) showed; this steroid- 
induced gonadal atrophy is due to a selective inhibition of pituitary function 
since it does not occur when gonadotrophin is administered concurrently with 
testosterone (16). The depression of ovarian function by some steroids in the 
androstane series was seen often in the present experiments and, no doubt, it is 
a factor in the restraint of tumor growth in intact rats but its importance is not 
primary because of considerations  which follow. 
Although many of the androstane derivatives which retarded the growth of 
mammary fibroadenoma  induced  a  profound decrease  in  ovarian  size and 
abolished keratin formation in the vagina, these effects were not essential for 
the retardation of tumor growth.  It was found that testosterone,  0.1 rag. and 
androsterone,  1 to 3 rag. brought about an extensive restraint of tumor growth 
while the size of the ovaries was not less than that of uninjected controls; more- 
over, in these rats the formation of keratin in the vagina was typical of estrus. 
It is certain that in these animals, inhibition of tumor growth had occurred in 
rats in which estrogenic function of the ovary was preserved despite the admin- 
istration of the steroids in the dosage specified. 
Moreover,  it was discovered in the experiments  that the administration of 
dihydrotestosterone to ovariectomized  rats induced greater restraint of mam- 
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It would appear from this observation that there are extra-ovarian factors in 
the rat, as in man, which stimulate growth of mammary tumors and that these 
are suppressed by the inhibitory androstane steroids.  It has been shown that 
the adrenal glands (17) and the pituitary (18) secrete hormones that maintain 
human mammary cancer, since regression of the neoplasm follows the removal 
of these endocrine glands in certain cases. 
The massive stimulation of growth of mammary fibroadenoma which attends 
the administration of certain steroids was overcome by the concurrent injection 
of dihydrotestosterone. In earlier  work  (1)  it  had  been  shown  that  critical 
doses  of phenolic  estrogens  and  large  doses  of progesterone  stimulated the 
growth of the mammary tumor in ovariectomized rats. In the present experi- 
ments it was observed that the growth of this tumor in intact adult female rats 
was much accelerated by the administration of estradiol-1715, 1 ~g. and proges- 
terone,  4  mg.  when  these  compounds  were injected singly or  together. The 
stimulation of tumor growth by these steroids was nullified by the administra- 
tion of dihydrotestosterone, 1 mg. simultaneously,  whereas the growth of the 
mammary gland was enhanced.  The most reasonable  explanation  of these re- 
markable  effects  of  the  androstane  compounds  is  differential  physiologic 
activity at the cell surfaces of the tumor and the mammary epithelium respec- 
tively. Certainly in the  benign  mammary tumor dihydrotestosterone, while 
itself  incapable  of stimulating growth  of  the  tumor cells, can prevent  the 
growth-stimulating effects of estradiol-1713 and progesterone;  in  the normal 
mammary gland it promotes the growth of the epithelial cells regardless of the 
presence  or absence  of the powerful  growth-promoting  compounds  of other 
steroid categories. 
It is noteworthy that dihydrotestosterone was unable to prevent the growth 
of  an  unusually malignant mammary fibroadenoma  in  hypophysectomized 
rats. 
SUMMARY 
Many members of the androstane series profoundly retarded the growth of a 
transplanted benign mammary fibroadenoma of the rat; the restraint of tumor 
growth was in direct proportion to the amount of the administered compound 
until its maximal effect was achieved.  Certain steroids  closely related to the 
androstane inhibitors accelerated  the growth of the tumor. These effects of 
divergent sort depend on the molecular structure of the steroid. 
The molecular structure of androstane derivatives,  which is of high signifi- 
cance in modifying the rate of growth of the benign mammary tumor, consists 
of multiple components. These include (a) the presence and number of ketone 
and hydroxyl groups  in special orientation at  specific sites,  (b)  the sites  of 
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hydrogenation  of alkyl groups at designated  molecular  positions.  These mul- 
tiple factors determine whether androstane  compounds will inhibit  growth of 
the tumor, enhance it, or fail to influence its growth. 
The androstane compounds which caused either the restraint  or the promo- 
tion of tumor growth had the common property of inducing proliferation of the 
normal mammary epithelium. 
Two mechanisms are involved in the restraint  of growth of mammary fibro- 
adenoma by androstane inhibitors. The primary effect is the abolition of action 
of phenolic estrogens  and  progesterone  when dihydrotestosterone  is adminis- 
tered  concurrently,  presumably  through  direct  action at the tumor cell level 
A secondary contributory suppressive effect is the depression of ovarian activ- 
ity,  and  consequently  of  the  production  of  phenolic  estrogens  and  proges- 
terone, by these compounds. 
Transplanted  mammary fibroadenoma in the rat possesses neoplastic traits 
and  also  some growth properties  of normal  mammary  epithelium;  inhibition 
of these latter by hormonal methods commonly retarded the growth of the tu- 
mor. But in hypophysectomized rats dihydrotestosterone failed to inhibit  the 
growth of a mammary fibroadenoma with unusually low hormonal dependence 
as determined by functional tests of its growth. 
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EXPLANATION OF PLATE 42 
FIG. 1.  Mammary fibrosdenomas  harvested from 2 groups  of rats injected  with 
estradiol-17~,  1 ~g. and progesterone,  4 rag. (the upper tumors)  and with the same 
compounds  in identical  dosage supplemented  with  dihydrotestosterone,  1 rag.  (the 
lower tumors). THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  105  PLATE  42 
(Huggins and Mainzer: Hormonal influences on mammary tumors. II) 